Leading Infectious Disease Biomaterial Manufacturer

Copan FLOQSwab® and Liquid Control Products
- Clinical Diagnostics,
- Proficiency Programs,
- Training, Verification and Development
Antigens for Diagnostic Test Manufacturers
Viral Transport Medium – DxTM™

Microbix Announces Initiation of Normal Course Issuer Bid

For Repurchase of up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, December 4, 2025 – Microbix Biosystems Inc. (TSX:...

Microbix & Seegene Mexico Collaborate to Improve Test Accuracy

announce that Microbix external third-party quality assessment products (QAPs®) will be used to support the clinical use of the Allplex™ and Anyplex™ molecular multiplex assays of Seegene Mexico for detecting infection with high-risk types of the human papilloma virus (HPV).

Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests

announce that Microbix external third-party quality assessment products (REDx™FLOQ® QAPs®) will be used to support SEKISUI’s U.S. commercialization of the molecular point-of-care assay for diagnosis of COVID/Flu A/Flu B using the Metrix® platform from Aptitude Medical Systems, Inc. (Aptitude).

QAPS

Why choose Microbix Quality Assessment Products (QAPs)? Find out more.

infectious-diseas-antigens-3_55600834-e67d-4aa2-ad6b-59096ce3b3c8

INFECTIOUS DISEASE ANTIGENS

Microbix produces one of the world’s broadest range of infectious disease antigens.

PARTNERSHIP OPPORTUNITIES

Microbix has a partnership opportunity. Check it out here.

Our Commitment to Quality

Our quality process ensures our customers receive products that meet and exceed their needs and expectations. Our quality management system takes into consideration regulatory requirements that are applicable to the type of products we manufacture and the industries we serve.